334 related articles for article (PubMed ID: 29132233)
1. Prospects for modulating the CD40/CD40L pathway in the therapy of the hyper-IgM syndrome.
Meng X; Yang B; Suen WC
Innate Immun; 2018 Jan; 24(1):4-10. PubMed ID: 29132233
[TBL] [Abstract][Full Text] [Related]
2. A single-center study points to diverse features and outcome in patients with Hyperimmunoglobulin M Syndrome and Class- Switch Recombination defects.
Akarsu A; Halaçlı S; Tan Ç; Kuşkonmaz B; Küpesiz A; Çetinkaya D; Sanal Ö; Tezcan İ; Çağdaş D
Scand J Immunol; 2022 Nov; 96(5):e13213. PubMed ID: 36808635
[TBL] [Abstract][Full Text] [Related]
3. The hyper IgM syndromes.
Qamar N; Fuleihan RL
Clin Rev Allergy Immunol; 2014 Apr; 46(2):120-30. PubMed ID: 23797640
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and genetic analysis of Taiwanese patients with the hyper IgM syndrome phenotype.
Lee WI; Huang JL; Yeh KW; Yang MJ; Lai MC; Chen LC; Ou LS; Yao TC; Lin SJ; Jaing TH; Chen SH; Hsieh MY; Yu HH; Chien YH; Shyur SD
Pediatr Infect Dis J; 2013 Sep; 32(9):1010-6. PubMed ID: 23538518
[TBL] [Abstract][Full Text] [Related]
5. Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations.
Aghamohammadi A; Parvaneh N; Rezaei N; Moazzami K; Kashef S; Abolhassani H; Imanzadeh A; Mohammadi J; Hammarström L
J Clin Immunol; 2009 Nov; 29(6):769-76. PubMed ID: 19575287
[TBL] [Abstract][Full Text] [Related]
6. Class-Switch Recombination (CSR)/Hyper-IgM (HIGM) Syndromes and Phosphoinositide 3-Kinase (PI3K) Defects.
Jhamnani RD; Nunes-Santos CJ; Bergerson J; Rosenzweig SD
Front Immunol; 2018; 9():2172. PubMed ID: 30319630
[TBL] [Abstract][Full Text] [Related]
7. Genetic Analysis of Patients with Two Different Types of Hyper IgM Syndrome.
Alizadeh Z; Mazinani M; Houshmand M; Shakerian L; Nourizadeh M; Pourpak Z; Fazlollahi MR
Immunol Invest; 2018 Oct; 47(7):745-753. PubMed ID: 30081731
[TBL] [Abstract][Full Text] [Related]
8. Autoimmunity in hyper-IgM syndrome.
Jesus AA; Duarte AJ; Oliveira JB
J Clin Immunol; 2008 May; 28 Suppl 1():S62-6. PubMed ID: 18246414
[TBL] [Abstract][Full Text] [Related]
9. CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance.
Hervé M; Isnardi I; Ng YS; Bussel JB; Ochs HD; Cunningham-Rundles C; Meffre E
J Exp Med; 2007 Jul; 204(7):1583-93. PubMed ID: 17562816
[TBL] [Abstract][Full Text] [Related]
10. Update on the hyper immunoglobulin M syndromes.
Davies EG; Thrasher AJ
Br J Haematol; 2010 Apr; 149(2):167-80. PubMed ID: 20180797
[TBL] [Abstract][Full Text] [Related]
11. Circulating Follicular Helper and Follicular Regulatory T Cells Are Severely Compromised in Human CD40 Deficiency: A Case Report.
Cicalese MP; Gerosa J; Baronio M; Montin D; Licciardi F; Soresina A; Dellepiane RM; Miano M; Baselli LA; Volpi S; Dufour C; Plebani A; Aiuti A; Lougaris V; Fousteri G
Front Immunol; 2018; 9():1761. PubMed ID: 30131802
[TBL] [Abstract][Full Text] [Related]
12. First report of the Hyper-IgM syndrome Registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes.
Cabral-Marques O; Klaver S; Schimke LF; Ascendino ÉH; Khan TA; Pereira PV; Falcai A; Vargas-Hernández A; Santos-Argumedo L; Bezrodnik L; Moreira I; Seminario G; Di Giovanni D; Raccio AG; Porras O; Weber CW; Ferreira JF; Tavares FS; de Carvalho E; Valente CF; Kuntze G; Galicchio M; King A; Rosário-Filho NA; Grota MB; dos Santos Vilela MM; Di Gesu RS; Lima S; de Souza Moura L; Talesnik E; Mansour E; Roxo-Junior P; Aldave JC; Goudouris E; Pinto-Mariz F; Berrón-Ruiz L; Staines-Boone T; Calderón WO; del Carmen Zarate-Hernández M; Grumach AS; Sorensen R; Durandy A; Torgerson TR; Carvalho BT; Espinosa-Rosales F; Ochs HD; Condino-Neto A
J Clin Immunol; 2014 Feb; 34(2):146-56. PubMed ID: 24402618
[TBL] [Abstract][Full Text] [Related]
13. Novel and recurrent AID mutations underlie prevalent autosomal recessive form of HIGM in consanguineous patients.
Ouadani H; Ben-Mustapha I; Ben-ali M; Ben-khemis L; Larguèche B; Boussoffara R; Maalej S; Fetni I; Hassayoun S; Mahfoudh A; Mellouli F; Yalaoui S; Masmoudi H; Bejaoui M; Barbouche MR
Immunogenetics; 2016 Jan; 68(1):19-28. PubMed ID: 26545377
[TBL] [Abstract][Full Text] [Related]
14. Pitfalls of "hyper"-IgM syndrome: a new CD40 ligand mutation in the presence of low IgM levels. A case report and a critical review of the literature.
Heinold A; Hanebeck B; Daniel V; Heyder J; Tran TH; Döhler B; Greil J; Müller FM
Infection; 2010 Dec; 38(6):491-6. PubMed ID: 20981468
[TBL] [Abstract][Full Text] [Related]
15. Inducible CO-stimulator molecule, a candidate gene for defective isotype switching, is normal in patients with hyper-IgM syndrome of unknown molecular diagnosis.
Lee WI; Zhu Q; Gambineri E; Jin Y; Welcher AA; Ochs HD
J Allergy Clin Immunol; 2003 Nov; 112(5):958-64. PubMed ID: 14610488
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of enteric IgA in an unimmunised mouse model of Hyper IgM syndrome derived from gut-associated secondary lymph organs even in the absence of germinal centres.
Hernandez-Cazares F; Maqueda-Alfaro RA; Lopez-Saucedo C; Martinez-Barnetche J; Yam-Puc JC; Estrada-Parra S; Flores-Romo L; Estrada-Garcia T
Front Cell Infect Microbiol; 2023; 13():1172021. PubMed ID: 37457961
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome.
Lee WI; Torgerson TR; Schumacher MJ; Yel L; Zhu Q; Ochs HD
Blood; 2005 Mar; 105(5):1881-90. PubMed ID: 15358621
[TBL] [Abstract][Full Text] [Related]
18. The hyper IgM syndrome--an evolving story.
Etzioni A; Ochs HD
Pediatr Res; 2004 Oct; 56(4):519-25. PubMed ID: 15319456
[TBL] [Abstract][Full Text] [Related]
19. Different molecular behavior of CD40 mutants causing hyper-IgM syndrome.
Lanzi G; Ferrari S; Vihinen M; Caraffi S; Kutukculer N; Schiaffonati L; Plebani A; Notarangelo LD; Fra AM; Giliani S
Blood; 2010 Dec; 116(26):5867-74. PubMed ID: 20702779
[TBL] [Abstract][Full Text] [Related]
20. Targeted gene editing restores regulated CD40L function in X-linked hyper-IgM syndrome.
Hubbard N; Hagin D; Sommer K; Song Y; Khan I; Clough C; Ochs HD; Rawlings DJ; Scharenberg AM; Torgerson TR
Blood; 2016 May; 127(21):2513-22. PubMed ID: 26903548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]